Abstract

To investigate, by systematically reviewing the literature, whether the attention-deficit/hyperactivity disorder (ADHD) polygenic risk score (PRS) associates with ADHD and related traits in independent clinical and population samples. PubMed, Embase and PsychoInfo were systematically searched, alongside study bibliographies. Quality assessments were conducted, and a best-evidence synthesis was applied. Studies were excluded when the predictor was not based on the latest ADHD genome-wide association study, when PRS was not based on genome-wide results, or when the study was a review. Initially, 197 studies were retrieved (February 22, 2020), and a second search (June 3, 2020) yielded a further 49 studies. From both searches, 57 studies were eligible, and 44 studies met inclusion criteria. Included studies were published in the last 3 years. Over 80% of the studies were rated excellent, based on a standardized quality assessment. Evidence of associations between ADHD PRS and the following categories was strong: ADHD, ADHD traits, brain structure, education, externalizing behaviors, neuropsychological constructs, physical health, and socioeconomic status. Evidence for associations with addiction, autism, and mental health were mixed and were, so far, inconclusive. Odds ratios for PRS associating with ADHD ranged from 1.22% to 1.76%; variance explained in dimensional assessments of ADHD traits was 0.7% to 3.3%. A new wave of high-quality research using the ADHD PRS has emerged. Eventually, symptoms may be partly identified based on PRS, but the current ADHD PRS is useful for research purposes only. This review shows that the ADHD PRS is robust and reliable, associating not only with ADHD but many outcomes and challenges known to be linked to ADHD.

Highlights

  • Abstract] OR “Hyperactive”[Title/Abstract] OR “attention deficit hyperactivity disorder“[Title/Abstract] OR “Attention problems”[Title/Abstract]) AND (“Polygenic risk score”[Title/Abstract] OR “Polygenic score”[Title/Abstract])

  • attention-deficit/hyperactivity disorder (ADHD) symptoms (p < .01) ADHD polygenic risk score (PRS) predicted 17.0% increased odds in the High Decreasing (OR [ 1.17 95% CI [ 1.002, 1.366, p [ .05) and 8.0% increased odds in the Moderate (OR [ 1.08, 95% CI [ 1.004, 1.163, p [.03) externalizing trajectories, but was not associated with the Low Increasing trajectory, relative to the Normal trajectory group There was no longer evidence of direct associations between ADHD PRS on externalizing trajectory groups relative to the Normal trajectory group once mediators were added to the models

  • Association between polygenic risk for ADHD and brain growth was determined for the LONG cohort association between polygenic risk for ADHD and brain growth was determined for the LONG cohort ADHD ascertained using clinician-administered Parent Diagnostic Interview for Children and Adolescents[107] Longitudinal growth in volume across 2 time points modeled linearly for 4 brain divisions: cerebral cortex, basal ganglia, cerebellum, cerebral white matter, and 1 region of interest: right lateral prefrontal cortex Covariates: adjusted for age at baseline scan, interscan interval, sex, and Principal components (PCs)

Read more

Summary

Introduction

Abstract] OR “Hyperactive”[Title/Abstract] OR “attention deficit hyperactivity disorder“[Title/Abstract] OR “Attention problems”[Title/Abstract]) AND (“Polygenic risk score”[Title/Abstract] OR “Polygenic score”[Title/Abstract]). Bibliographies of selected studies were searched (by NB). A first search was conducted February 22, 2020, and a second search June 3, 2020. All abstracts were inspected by 2 reviewers (TJCP and NB). Studies were excluded when the following conditions were met: (1) the predictor was not an ADHD PRS; (2) the PRS was not based on genome-wide results (but, for example, on a certain selection of SNPs); (3) the ADHD PRS was not based on the latest GWAS results of ADHD17; or (d) the study was a review

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call